Market News
Why Eli Lilly Investors Should Ignore Novo Nordisk’s Obesity Pill Lead
Novo Nordisk just scored FDA approval for the first obesity pill, sending its shares soaring while Eli Lilly dipped. But...
23/12/2025
2 views